Other competition news
Recent competition outcomes
MedTech and In Vitro Diagnostic Co-operatives: Funding of £14.25 million has been provided to 11 NIHR MedTech and In Vitro Diagnostic Co-operatives to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. The NIHR MICs with launch 1 January 2018 replacing the NIHR Healthcare Technology Co-operatives and NIHR Diagnostic Evidence Co-operatives, incorporating and retaining the remits of both.
Patient Safety Translational Research Centres: On 13 February Public Health and Innovation Minister, Nicola Blackwood has today announced a £17 million investment into three NIHR Patient Safety Translational Research Centres (PSTRCs). The funding will be split between Imperial College NHS Trust and Imperial College London (over £7 million), Salford Royal NHS Foundation Trust and University of Manchester (over £6 million) and Bradford Teaching Hospitals NHS Foundation Trust and University of Leeds (£3 million), to fund the two existing PSTRCs in London and Manchester and a new PSTRC in Yorkshire. The investment will be spent on patient safety research with the centres aiming to turn patient safety discoveries into practice, with previous research undertaken in Manchester and London already having an impact on NHS frontline services.
Clinical Research Facilities: Following a competitive application and assessment process, funding has been awarded to 23 NHS organisations to be provided from 1 April 2017 to 31 March 2022. The purpose of the scheme is to provide NIHR funding to meet the necessary recurrent NHS infrastructure costs and NHS Support Costs of funded, world-class, early translational (experimental medicine) research that needs to be undertaken in dedicated, purpose-built CRFs in England, and ensure that funding is targeted appropriately.
Biomedical Research Centres: Following an open competition, funding was awarded to 20 NHS and university partnerships across England to host the development of new, ground-breaking treatments, diagnostics, prevention and care for patients in a wide range of diseases like cancer and dementia. On the announcement (14 September 2016), Chief Scientific Advisor Professor Chris Whitty said: "The future of NHS care depends on the science we do now. This new funding will enable clinical researchers to keep pushing for medical breakthroughs. The NIHR biomedical research centres announced today offer huge potential benefits for patients across the country."